Ultrasound with microbubbles for non-healing leg ulcers from peripheral arterial disease
Tests ultrasound with microbubbles for healing stubborn leg wounds in peripheral arterial disease.
Key facts
- Who runs it
- University of Virginia
- Where
- Charlottesville, United StatesSee the site
- Trial code
- Registry title
- Ultrasound Cavitation Therapy for CLI
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Jan 2023
- Planned end
- 28 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Acoustic cavitation of ultrasound enhancing agents
- Record updated
- 1 March 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe peripheral arterial disease (narrowed leg arteries) and a leg or foot ulcer that has not healed. It tests ultrasound with contrast microbubbles to help wounds heal.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Critical limb ischemia (Rutherford class IV-VI) with an ulcer from poor blood flow that has not changed in the prior 3 months.
- Biomarker or test result
- Peripheral arterial disease shown by an ankle-brachial index below 0.9 or by non-compressible vessels.
Main reasons for not taking part
- Another major illness affecting the limb, such as muscle disease, blood diseases that affect flow, or severe heart failure (NYHA class IV)
- Pregnant or breastfeeding
- Allergy to any ultrasound contrast agent or to polyethylene glycol (PEG, macrogol)
- Unstable blood pressure (systolic BP <90 mm Hg or needing drugs to raise blood pressure)
- Amputation or a procedure to restore blood flow expected within the next 1 month
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Known history of unilateral or bilateral PAD diagnosed by reduced ankle-brachial index (<0.9) or non-compressible vessels
- Diagnosis of CLI (Rutherford class IV-VI), and a non-healing ischemic ulcer defined as no change in the prior 3 months
Who cannot take part
- Major medical illness other than PAD affecting the limb (muscle disease, blood diseases that influence flow or rheology, severe heart failure [NYHA class IV])
- Hypersensitivity to any ultrasound contrast agent or to polyethylene glycol (PEG, macrogol)
- Pregnant or lactating females
- Hemodynamic instability (hypotension with systolic BP <90 mm Hg, need for vasopressors)
- Expected amputation or revascularization procedure within the ensuing 1 month
Where in United States
- University of VirginiaCharlottesville, United StatesContact: Jonathan Lindner, MDTaking people
About the trial
What the trial wants to find out
In this study, we will explore how ultrasound exposure of ultrasound contrast agents, which produces beneficial shear-mediated bioeffects, can be used to treat patients with severe non-healing ulcers secondary to peripheral arterial disease (PAD). The primary outcome measure is whether ultrasound exposure to microbubble contrast agents in the inflow artery and at the wound site can accelerate wound healing. A secondary outcome measure is whether cavitation-related changes occur in tissue perfusion in the treated limb and wound measured by ultrasound perfusion imaging and skin flow.
The 2 groups in the trial
- Cavitation therapyTreatment being tested
Subjects treated with cavitation energy
Treatment: Acoustic cavitation of ultrasound enhancing agents
- ControlNo study treatment, for comparison
Control subjects not treated with cavitation energy
Results explained
A paper that names this trial, explained in plain words.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ultrasound Cavitation for Treatment of Non-healing Ulcers in Critical Limb Ischemia
- Plain-language title
- Ultrasound with microbubbles for non-healing leg ulcers from peripheral arterial diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Ultrasound Cavitation of Microbubbles Augments Limb Perfusion and Promotes Ulcer Healing in Chronic Limb-Threatening Ischemia.JACC. Cardiovascular imaging, 2026
- Record updated
- 1 March 2023